Maximum quantity allowed is 999
请选择数量
CAS RN: 503468-95-9 | 产品编码: N1110
NU 7441
![NU 7441 No-Image](/medias/N1110.jpg?context=bWFzdGVyfHJvb3R8NTExMDZ8aW1hZ2UvanBlZ3xhR1V6TDJoaE9TODRPVEl5TnpVMU1UY3dNek0wTDA0eE1URXdMbXB3Wnd8NTZiOGJlNDlhOWUwNDljZGMzMzc2NzZjMDM1MmQ0OTVkYzA1NTRlYzc5NjUzNTI5YjMyYzY4MDRiZDZjNjc3ZA)
补充产品信息:
This product is unavailable in the U.S.
产品编码 | N1110 |
纯度/分析方法 | >98.0%(HPLC) |
分子式/分子量 | C__2__5H__1__9NO__3S = 413.49 |
外观与形状(20°C) | 固体 |
储存温度 | 冷冻 (-20°C) |
应避免的情况 | 加热 |
包装和容器 | 10MG-Glass Bottle with Plastic Insert (查看图片) |
CAS RN | 503468-95-9 |
Reaxys-RN | 9876245 |
MDL编号 | MFCD11983069 |
技术规格
Appearance | White to Gray to Brown powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Elemental analysis(Nitrogen) | 3.00 to 3.80 % |
物性(参考值)
熔点 | 222 °C(dec.) |
最大吸收波长 | 233(EtOH) nm |
GHS
相关法规
运输信息
HS编码* | 2934.99-000 |
应用
CRISPR Genome Editing
DNA-dependent protein kinase (DNA-PK) inhibitor, NU 7441, reduces the frequency of non-homologous end joining (NHEJ) while increasing the rate of homology-directed recombination (HDR) following Cas9-mediated DNA cleavage.1)
References
- 1) Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing
应用
NU7441: DNA-dependent protein kinase (DNA-PK) inhibitor
Recently, the inhibition of DNA repair is emerging as a new therapeutic strategy for cancer treatment. NU7441 (KU57788) is a potent and selective inhibitor of the DNA repair enzyme DNA-dependent protein serine/threonine kinase (DNA-PK) which is activated by DNA damage and mediates DNA double-strand break repair. (The product is for research purpose only.)
References
- Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries
- Discovery of Potent Chromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Using a Small-Molecule Library Approach
- Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441
- DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia
- Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
TCIMail
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。